Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

Historical Holders from Q3 2016 to Q3 2025

Symbol: ADPT on Nasdaq
Type / Class: Equity / Common stock, par value $0.0001 per share
Shares outstanding: 151,865,218
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 145,445,972
Holdings value: $2,175,466,292
% of all portfolios: 0.003%
Number of holders: 268
Number of buys: 144
Number of sells: -107
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	6.7%		$78,532,683		9,940,846		BlackRock, Inc.	31 Mar 2025
Sumitomo Mitsui Trust Group, Inc.	4.6%		$53,981,782		6,833,137		Sumitomo Mitsui Trust Group, Inc.	31 Dec 2024
Nikko Asset Management Americas, Inc.	4.63%		$53,981,782		6,833,137		Nikko Asset Management Americas, Inc.	31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC	4.3%		$49,711,809		6,292,634		Millennium Management LLC	31 Dec 2024
Rubric Capital Management LP	4.12%		$72,889,139		6,256,847		Rubric Capital Management LP	30 Jun 2025
ARK Investment Management LLC	2.9%	-27.2%	$40,863,635	-$15,506,311	4,398,669	-27.5%	ARK Investment Management LLC	31 May 2025

Institutional Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	145,445,972	$2,175,466,292	-$14,778,534	$498,168	$351,560	$14.96	268
2025 Q2	148,178,882	$1,726,248,551	-$46,396,273	$293,580	$1,961,860	$11.65	240
2025 Q1	152,930,142	$1,136,093,247	+$68,698,942	$355,154	$329,149	$7.43	222
2024 Q4	143,282,424	$858,588,192	+$3,881,916	$163,158	$117,566	$6	204
2024 Q3	143,105,692	$732,467,776	-$27,674,373	$217,600	$352,256	$5.12	184
2024 Q2	148,655,164	$538,029,201	+$26,127,842	$202,720	$30,408	$3.62	173
2024 Q1	142,447,362	$456,622,976	-$10,170,998	$459,351	$8,346	$3.21	186
2023 Q4	143,639,172	$703,966,709	+$9,702,761	$490,980	$281,750	$4.9	194
2023 Q3	140,492,459	$765,707,625	+$15,429,772	$177,125	$205,465	$5.45	187
2023 Q2	137,082,822	$919,786,637	+$21,850,661	$496,540	$904,508	$6.71	208
2023 Q1	133,849,942	$1,179,397,231	+$14,000,370	$190,728	$2,231,241	$8.83	223
2022 Q4	132,787,161	$1,014,264,343	+$14,824,828	$269,692	$5,508,440	$7.64	216
2022 Q3	131,007,037	$931,519,109	-$31,344,186	$508,000	$855,000	$7.12	205
2022 Q2	134,391,278	$1,083,708,756	+$49,040,887	$375,000	$1,036,000	$8.09	196
2022 Q1	125,563,937	$1,741,620,797	-$42,426,089	$1,568,000	$1,118,000	$13.88	207
2021 Q4	123,444,543	$3,462,001,567	+$139,816,088	$1,099,000	$1,688,516	$28.06	208
2021 Q3	117,860,461	$4,003,739,752	-$434,478	$4,055,000	$4,262,114	$33.99	212
2021 Q2	117,427,979	$4,796,005,013	+$143,202,294	$7,335,000	$18,721,000	$40.86	226
2021 Q1	113,768,226	$4,579,995,207	-$122,834,155	$14,686,000	$21,415,000	$40.26	238
2020 Q4	114,044,316	$6,743,577,628	+$149,068,690	$10,288,000	$25,662,000	$59.13	244
2020 Q3	111,322,127	$5,410,179,736	+$503,359,137	$4,951,000	$15,289,000	$48.63	206
2020 Q2	101,046,823	$4,886,712,149	+$212,566,003	$5,729,000	$9,923,000	$48.38	192
2020 Q1	96,830,392	$2,689,585,555	+$284,953,611	$3,475,000	$2,064,000	$27.78	144
2019 Q4	86,210,177	$2,579,382,908	+$148,626,753	$4,961,000	$1,475,000	$29.92	129
2019 Q3	81,041,176	$2,492,319,624	+$38,889,817	$2,936,000	$3,075,000	$30.9	116
2019 Q2	78,228,081	$3,735,247,853	+$3,731,000,860			$48.3	110
2019 Q1	103,941	$4,247,000				$40.86	1
2016 Q4	0	$0	-$10,117				0
2016 Q3	235	$10,117	+$10,117			$43.05	1